| Lung Cancer |
1 |
1 |
| Biologic Therapy |
0 |
0.75 |
| Lung Metastases |
0 |
0.95 |
| Non-Small Cell Lung Cancer |
0 |
0.99 |
| Skin Cancer |
0 |
0.62 |
| Cancer |
0 |
0.58 |
| Toxicology |
0 |
0.58 |
| Tumor |
0 |
0.58 |
| Genomic Medicine |
0 |
0.52 |
| Small Cell Lung Cancer |
0 |
0.51 |
| Targeted Cancer Therapy |
0 |
0.46 |
| Interleukin-2 |
0 |
0.28 |
| Immunotherapy |
0 |
0.26 |
| Lung |
0 |
0.26 |
| Tobacco Cessation |
0 |
0.2 |
| Smoking |
0 |
0.16 |
| T-Lymphocyte |
0 |
0.9 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.07 |
| HIV Infection |
0 |
0.07 |
| Melanoma |
0 |
0.07 |
| Brachial |
0 |
0.05 |
| Dorsum |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Immunology |
0 |
0.05 |
| Interleukin |
0 |
0.05 |
| Lymphocytes |
0 |
0.05 |
| New York |
0 |
0.05 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.05 |
| Oncogene |
0 |
0.05 |
| Refractory |
0 |
0.05 |